Caribou Biosciences Competitors and Similar CompaniesClear all

Caribou Biosciences's competitors and similar companies include Biocytogen Boston, Editas Medicine, Creyon Bio and Applied Biological Materials.

	Caribou Biosciences Caribou Biosciences is a clinical-stage CRISPR genome-editing biopharmaceutical company.	Biocytogen Boston Biocytogen Boston is a company that provides antibody drug development solutions.	Editas Medicine Editas Medicine is engaged in discovering and developing a novel class of genome editing therapeutics.	Creyon Bio Creyon Bio is a reinventing drug development company that develops oligonucleotide-based medicines (OBMs).	Applied Biological Materials Applied Biological Materials is a company that provides research reagents.
Founding Date	Founding Date 2012	Founding Date 2008	Founding Date 2013	Founding Date 2019	Founding Date 2004
Type	Type Public	Type Subsidiary	Type Public	Type Private	Type Private
Tags	Tags Healthcare bioengineering biotech genetics	Tags Healthcare biotech drug development genetics	Tags Healthcare bioengineering biotech genetics	Tags Healthcare bioengineering biotech genetics	Tags Healthcare bioengineering biotech genetics
Locations	Locations Berkeley, US HQ	Locations Waltham, US HQ Beijing, CN Nantong, CN Shanghai, CN Heidelberg, DE San Diego, US San Francisco, US	Locations Cambridge, US HQ Boulder, US Cambridge, US	Locations Carlsbad, US HQ Bengaluru, IN Durham, US	Locations Richmond, CA HQ Richmond, CA Ferndale, US
Employees	Employees 1477% decrease	Employees 1833% increase	Employees 20816% increase	Employees 522% increase	Employees 635% increase
Valuation ($)	Valuation ($) 174.4 m	Valuation ($) N/A	Valuation ($) 256.5 m	Valuation ($) N/A	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) $11.2m (FY, 2025)	Revenue (est.) N/A	Revenue (est.) $40.5m (FY, 2025)	Revenue (est.) N/A	Revenue (est.) N/A
Net income	Net income ($148.1m) (FY, 2025)	Net income N/A	Net income ($160.1m) (FY, 2025)	Net income N/A	Net income N/A
Funding
Total funding raised	Total funding raised $ 159.5m	Total funding raised $ 284.3m	Total funding raised $ 210m	Total funding raised $ 40m	Total funding raised N/A